SAN RAMON, Calif., August 3, 2020—CooperVision has hired Rajeev Garg, PhD, as Global Head of Myopia Management Strategy. In this newly created role, he leads initiatives including market development, acquisitions and joint ventures, technology licensing, and lifecycle management in this growing segment of vision care.
Dr. Garg brings more than 20 years of experience in driving innovation and growth in healthcare, including optometry and ophthalmology. He most recently served as Executive Director, Surgical Marketing at Bausch + Lomb, and prior to that in senior marketing roles within Johnson & Johnson’s cataract, contact lens and sterilization businesses. Earlier in his career, he focused on pharmaceuticals development at Abbott and Merck.
“Continuing to advance myopia management requires expanded investment in science and technology, as well as adding to an already strong team of visionary, experienced and passionate people,” said Dr. Juan Carlos Aragón, President, CooperVision Specialty EyeCare. “Garg’s proven expertise will be invaluable as we pioneer new techniques, introduce new products, and establish new collaborations to address the global myopia epidemic.”
Dr. Garg received his PhD in chemical engineering (medical devices) from Princeton University, an MBA in strategy, healthcare and marketing from Northwestern University’s Kellogg School of Management, and a B.Tech in chemical engineering from the Indian Institute of Technology. He resides in California with his wife and family.
# # #
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of daily disposable, two-week and monthly contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism, presbyopia and childhood myopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Mike McDougall, APR, Fellow PRSA, McDougall Communications
firstname.lastname@example.org or +1-585-545-1815 (mobile)